糖尿病足血管病变的治疗进展
Progress in the Treatment of Diabetic Foot Vascular Disease
DOI: 10.12677/ACM.2024.141007, PDF,   
作者: 刘家辰, 白 超*：新疆医科大学第一附属医院消化血管外科中心血管甲状腺外科，新疆 乌鲁木齐
关键词: 糖尿病足血管病变；介入治疗；手术治疗；Diabetic Foot Vascular Disease； Interventional Therapy； Surgical Treatment
摘要: 糖尿病足溃疡是长期且管理不佳的糖尿病所常见的结果，足部溃疡的后果包括功能状态下降、感染、住院、下肢截肢和死亡，严重影响了糖尿病患者的生活质量及经济负担。外周血管系统的血运重建也是溃疡管理的关键组成部分。本文主要针对糖尿病足血管病变已成熟的技术(普通球囊血管成形术、裸金属支架、覆膜支架、自体静脉搭桥手术、开放式深静脉动脉化)与新技术(药物涂层球囊、药物洗脱支架、血栓动脉内膜切除术、改良球囊、经皮斑块切除术、血管内碎石术、经皮深静脉动脉化、生物可吸收支架)进行介绍，同时探求新的治疗方式，明确各个治疗方式之间的优越性及优缺点。
Abstract: Diabetic foot ulcer is a common result of long-term and poorly managed diabetes. The consequences of foot ulcer include decreased functional status, infection, hospitalization, lower limb amputation, and death, which seriously affect the quality of life and economic burden of patients with diabetes. Revascularization of the peripheral vascular system is also a key component of ulcer management. This article mainly focuses on the mature technologies (standard balloon angioplasty, bare metal stents, covered stents, autologous vein bypass surgery, open deep vein arterialization) and new technologies (drug-coated balloon, drug-eluting stents, thrombotic endarterectomy, modified bal-loon, percutaneous atherectomy, Intravascular lithotripsy, percutaneous deep vein arterialization, and angioplasty) of diabetic foot vascular disease. At the same time, new treatment methods are explored, and the advantages and disadvantages of each treatment method are clarified.
文章引用：刘家辰, 白超. 糖尿病足血管病变的治疗进展[J]. 临床医学进展, 2024, 14(1): 42-54. https://doi.org/10.12677/ACM.2024.141007

参考文献

[1] McDermott, K., Fang, M., Boulton, A.J.M., Selvin, E. and Hicks, C.W. (2023) Etiology, Epidemiology, and Disparities in the Burden of Diabetic Foot Ulcers. Diabetes Care, 46, 209-221. [Google Scholar] [CrossRef] [PubMed]
[2] Hinchliffe, R.J., Forsythe, R.O., Apelqvist, J., et al. (2020) Guidelines on Diagnosis, Prognosis, and Management of Peripheral Artery Disease in Patients with Foot Ulcers and Diabetes (IWGDF 2019 Update). Diabetes/Metabolism Research and Reviews, 36, e3276. [Google Scholar] [CrossRef] [PubMed]
[3] Graziani, L., Silvestro, A., Bertone, V., et al. (2007) Vascular Involvement in Diabetic Subjects with Ischemic Foot Ulcer: A New Morphologic Categorization of Disease Severity. European Journal of Vascular and Endovascular Surgery, 33, 453-460. [Google Scholar] [CrossRef] [PubMed]
[4] Narula, N., Dannenberg, A.J., Olin, J.W., et al. (2018) Pathology of Peripheral Artery Disease in Patients with Critical Limb Ischemia. Journal of the American College of Cardiology, 72, 2152-2163. [Google Scholar] [CrossRef] [PubMed]
[5] Taylor, G.I. and Palmer, J.H. (1987) The Vascular Territories (An-giosomes) of the Body: Experimental Study and Clinical Applications. British Journal of Plastic Surgery, 40, 113-141. [Google Scholar] [CrossRef] [PubMed]
[6] Jongsma, H., Bekken, J.A., Akkersdijk, G.P., Hoeks, S.E., Verhagen, H.J. and Fioole, B. (2017) Angiosome-Directed Revascularization in Patients with Critical Limb Ischemia. Journal of Vascular Surgery, 65, 1208-1219.e1. [Google Scholar] [CrossRef] [PubMed]
[7] Chuter, V., Schaper, N., Mills, J., et al. (2023) Effectiveness of Re-vascularisation for the Ulcerated Foot in Patients with Diabetes and Peripheral Artery Disease: A Systematic Review. Diabetes/Metabolism Research and Reviews, e3700. [Google Scholar] [CrossRef] [PubMed]
[8] Kurianov, P., Lipin, A., Antropov, A., et al. (2022) Propensity-Matched Analysis Does Not Support Angiosome-Guided Revascularization of Multilevel Peripheral Artery Disease (PAD). Vascular Medicine, 27, 47-54. [Google Scholar] [CrossRef] 
[9] Settembre, N., Biancari, F., Spillerova, K., Albäck, A., Söder-ström, M. and Venermo, M. (2020) Competing Risk Analysis of the Impact of Pedal Arch Status and Angio-some-Targeted Revascularization in Chronic Limb-Threatening Ischemia. Annals of Vascular Surgery, 68, 384-390. [Google Scholar] [CrossRef] [PubMed]
[10] Choke, E., Tang, T.Y., Cheng, S.C. and Tay, J.S. (2020) Treatment of Lower Limb Ischaemia in Patients with Diabetes. Diabetes/Metabolism Research and Reviews, 36, e3262. [Google Scholar] [CrossRef] [PubMed]
[11] Caradu, C., Lakhlifi, E., Colacchio, E.C., et al. (2019) Systematic Review and Updated Meta-Analysis of the Use of Drug-Coated Balloon Angioplasty versus Plain Old Balloon Angioplasty for Femoropopliteal Arterial Disease. Journal of Vascular Surgery, 70, 981-995.e10. [Google Scholar] [CrossRef] [PubMed]
[12] Lammer, J., Zeller, T., Hausegger, K.A., et al. (2013) Hepa-rin-Bonded Covered Stents versus Bare-Metal Stents for Complex Femoropopliteal Artery Lesions: The Randomized VIASTAR Trial (Viabahn Endoprosthesis with PROPATEN Bioactive Surface [VIA] versus Bare Nitinol Stent in the Treatment of Long Lesions in Superficial Femoral Artery Occlusive Disease). Journal of the American College of Cardi-ology, 62, 1320-1327. [Google Scholar] [CrossRef] [PubMed]
[13] Mwipatayi, B.P., Ouriel, K., Anwari, T., et al. (2020) A Systematic Review of Covered Balloon-Expandable Stents for Treating Aortoiliac Occlusive Disease. Journal of Vascular Surgery, 72, 1473-1486.e2. [Google Scholar] [CrossRef] [PubMed]
[14] Ohki, T., Kichikawa, K., Yokoi, H., et al. (2021) Long-Term Results of the Japanese Multicenter Viabahn Trial of Heparin Bonded Endovascular Stent Grafts for Long and Complex Lesions in the Superficial Femoral Artery. Journal of Vascular Surgery, 74, 1958-1967.e2. [Google Scholar] [CrossRef] [PubMed]
[15] Geraghty, P.J., Mewissen, M.W., Jaff, M.R., Ansel, G.M. and VIBRANT Investigators (2013) Three-Year Results of the VIBRANT Trial of VIABAHN Endoprosthesis versus Bare Nitinol Stent Implantation for Complex Superficial Femoral Artery Occlusive Disease. Journal of Vascular Surgery, 58, 386-395.e4. [Google Scholar] [CrossRef] [PubMed]
[16] Ichihashi, S., Takahara, M., Iida, O., et al. (2021) Clinical Impact of Stent Graft Thrombosis in Femoropopliteal Arterial Lesions. JACC: Cardiovascular Interventions, 14, 1137-1147. [Google Scholar] [CrossRef] [PubMed]
[17] Krankenberg, H., Zeller, T., Ingwersen, M., et al. (2017) Self-Expanding versus Balloon-Expandable Stents for Iliac Artery Occlusive Disease: The Randomized ICE Trial. JACC: Cardiovascular Interventions, 10, 1694-1704. [Google Scholar] [CrossRef] [PubMed]
[18] Gerhard-Herman, M.D., Gornik, H.L., Barrett, C., et al. (2017) 2016 AHA/ACC Guideline on the Management of Patients with Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation, 135, e726-e779. [Google Scholar] [CrossRef] 
[19] Bradbury, A.W., Adam, D.J., Bell, J., et al. (2010) Multi-centre Randomised Controlled Trial of the Clinical and Cost-Effectiveness of a Bypass-Surgery-First versus a Bal-loon-Angioplasty-First Revascularisation Strategy for Severe Limb Ischaemia Due to Infrainguinal Disease. The Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) Trial. Health Technology Assessment, 14. [Google Scholar] [CrossRef] [PubMed]
[20] Almasri, J., Adusumalli, J., Asi, N., et al. (2019) A Systematic Review and Meta-Analysis of Revascularization Outcomes of Infrainguinal Chronic Limb-Threatening Ischemia. European Journal of Vascular and Endovascular Surgery, 58, S110-S119. [Google Scholar] [CrossRef] [PubMed]
[21] Bradbury, A.W., Moakes, C.A., Popplewell, M., et al. (2023) A Vein Bypass First versus a Best Endovascular Treatment First Re-vascularisation Strategy for Patients with Chronic Limb Threatening Ischaemia Who Required an Infra-Popliteal, with or without an Additional More Proximal Infra-Inguinal Revascularisation Procedure to Restore Limb Perfusion (BASIL-2): An Open-Label, Randomised, Multicentre, Phase 3 Trial. The Lancet, 401, 1798-1809. [Google Scholar] [CrossRef] 
[22] Farber, A., Menard, M.T., Conte, M.S., et al. (2022) Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia. The New England Journal of Medicine, 387, 2305-2316. [Google Scholar] [CrossRef] 
[23] Peters, F., Behrendt, C.A. and IDOMENEO Collabo-rators (2023) Limb Related Outcomes of Endovascular vs. Open Surgical Revascularisation in Patients with Peripheral Arterial Occlusive Disease: A Report from the Prospective GermanVasc Cohort Study. European Journal of Vascular and Endovascular Surgery, 66, 85-93. [Google Scholar] [CrossRef] [PubMed]
[24] Nierlich, P., Enzmann, F.K., Metzger, P., et al. (2020) Alternative Venous Conduits for Below Knee Bypass in the Absence of Ipsilateral Great Saphenous Vein. European Journal of Vascular and Endovascular Surgery, 60, 403-409. [Google Scholar] [CrossRef] [PubMed]
[25] Ho, V.T., Gologorsky, R., Kibrik, P., et al. (2020) Open, Percuta-neous, and Hybrid Deep Venous Arterialization Technique for No-Option Foot Salvage. Journal of Vascular Surgery, 71, 2152-2160. [Google Scholar] [CrossRef] [PubMed]
[26] Schreve, M.A., Minnee, R.C., Bosma, J., Leijdekkers, V.J., Idu, M.M. and Vahl, A.C. (2014) Comparative Study of Venous Arterialization and Pedal Bypass in a Patient Cohort with Critical Limb Ischemia. Annals of Vascular Surgery, 28, 1123-1127. [Google Scholar] [CrossRef] [PubMed]
[27] Schreve, M.A., Vos, C.G., Vahl, A.C., et al. (2017) Venous Arte-rialisation for Salvage of Critically Ischaemic Limbs: A Systematic Review and Meta-Analysis. European Journal of Vascular and Endovascular Surgery, 53, 387-402. [Google Scholar] [CrossRef] [PubMed]
[28] Katsanos, K., Spiliopoulos, S., Kitrou, P., Krokidis, M. and Karna-batidis, D. (2018) Risk of Death Following Application of Paclitaxel-Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Journal of the American Heart Association, 7, e011245. [Google Scholar] [CrossRef] 
[29] Amlani, V., Falkenberg, M. and Nordanstig, J. (2021) The Current Status of Drug-Coated Devices in Lower Extremity Peripheral Artery Disease Interventions. Progress in Cardiovascular Diseases, 65, 23-28. [Google Scholar] [CrossRef] [PubMed]
[30] Zeller, T., Brechtel, K., Meyer, D.R., Noory, E., Beschorner, U. and Albrecht, T. (2020) Six-Month Outcomes from the First-in-Human, Single-Arm SELUTION Sus-tained-Limus-Release Drug-Eluting Balloon Trial in Femoropopliteal Lesions. Journal of Endovascular Therapy, 27, 683-690. [Google Scholar] [CrossRef] [PubMed]
[31] Tang, T.Y., Yap, C., Soon, S.X.Y., et al. (2021) World’s First Experience Treating TASC II C and D Tibial Occlusive Disease Using the Selution SLR Sirolimus-Eluting Balloon: Six-Month Results From the PRESTIGE Study. Journal of Endovascular Therapy, 28, 555-566. [Google Scholar] [CrossRef] [PubMed]
[32] Wang, J.L., Qin, Z., Wang, Z.J., et al. (2018) New Predictors of In-Stent Restenosis in Patients with Diabetes Mellitus Undergoing Percutaneous Coronary Intervention with Drug-Eluting Stent. Journal of Geriatric Cardiology, 15, 137-145.
[33] Reijnen, M.M.P.J., van Wijck, I., Brodmann, M., et al. (2023) Five-Year Outcomes after Paclitaxel Drug-Coated Balloon Treatment of Femoropopliteal Lesions in Diabetic and Chronic Limb-Threatening Ischemia Cohorts: IN.PACT Global Study Post Hoc Analysis. CardioVascular and Interventional Radiology, 46, 1329-1345. [Google Scholar] [CrossRef] [PubMed]
[34] Jia, X., Zhang, J., Zhuang, B., et al. (2016) Acotec Drug-Coated Balloon Catheter: Randomized, Multicenter, Controlled Clinical Study in Femoropopliteal Arteries: Evidence from the AcoArt I Trial. JACC: Cardiovascular Interventions, 9, 1941-1949. [Google Scholar] [CrossRef] [PubMed]
[35] Brodmann, M., Moscovic, M., Wang, J.C.C., et al. (2020) Re-al-World Experience with a Paclitaxel-Coated Balloon in Critical Limb Ischemia: 24-Month Subgroup Outcomes of BIOLUX P-III. JACC: Cardiovascular Interventions, 13, 2289-2299. [Google Scholar] [CrossRef] [PubMed]
[36] Sachar, R., Soga, Y., Ansari, M.M., et al. (2021) 1-Year Results from the RANGER II SFA Randomized Trial of the Ranger Drug-Coated Balloon. JACC: Cardiovascular Interventions, 14, 1123-1133. [Google Scholar] [CrossRef] [PubMed]
[37] Schneider, P.A., Laird, J.R., Tepe, G., et al. (2018) Treatment Effect of Drug-Coated Balloons Is Durable to 3 Years in the Femoropopliteal Arteries: Long-Term Results of the IN.PACT SFA Randomized Trial. Circulation: Cardiovascular Interventions, 11, e005891. [Google Scholar] [CrossRef] 
[38] Rosenfield, K., Jaff, M.R., White, C.J., et al. (2015) Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease. The New England Journal of Medicine, 373, 145-153. [Google Scholar] [CrossRef] 
[39] Krishnan, P., Faries, P., Niazi, K., et al. (2017) Stel-larex Drug-Coated Balloon for Treatment of Femoropopliteal Disease: Twelve-Month Outcomes from the Randomized ILLUMENATE Pivotal and Pharmacokinetic Studies. Circulation, 136, 1102-1113. [Google Scholar] [CrossRef] 
[40] Shishehbor, M.H., Scheinert, D., Jain, A., et al. (2023) Comparison of Drug-Coated Balloons vs Bare-Metal Stents in Patients with Femoropopliteal Arterial Disease. Journal of the American College of Cardiology, 81, 237-249. [Google Scholar] [CrossRef] [PubMed]
[41] Zeller, T., Micari, A., Scheinert, D., et al. (2020) The IN.PACT DEEP Clinical Drug-Coated Balloon Trial: 5-Year Outcomes. JACC: Cardiovascular Interventions, 13, 431-443. [Google Scholar] [CrossRef] [PubMed]
[42] Liistro, F., Porto, I., Angioli, P., et al. (2013) Drug-Eluting Balloon in Peripheral Intervention for below the Knee Angioplasty Evaluation (DEBATE-BTK): A Randomized Trial in Diabetic Patients with Critical Limb Ischemia. Circulation, 128, 615-621. [Google Scholar] [CrossRef] 
[43] Liistro, F., Angioli, P., Ventoruzzo, G., et al. (2020) Randomized Controlled Trial of Acotec Drug-Eluting Balloon versus Plain Balloon for Below-the-Knee Angio-plasty. JACC: Cardiovascular Interventions, 13, 2277-2286. [Google Scholar] [CrossRef] [PubMed]
[44] Ipema, J., et al. (2020) Editor’s Choice-Drug Coated Balloon An-gioplasty vs. Standard Percutaneous Transluminal Angioplasty in below the Knee Peripheral Arterial Disease: A System-atic Review and Meta-Analysis. European Journal of Vascular and Endovascular Surgery, 59, 265-275. [Google Scholar] [CrossRef] [PubMed]
[45] Patel, A., Irani, F.G., Pua, U., et al. (2021) Randomized Controlled Trial Comparing Drug-Coated Balloon Angioplasty versus Conventional Balloon Angioplasty for Treating Be-low-the-Knee Arteries in Critical Limb Ischemia: The SINGA-PACLI Trial. Radiology, 300, 715-724. [Google Scholar] [CrossRef] [PubMed]
[46] Byrne, R.A., Joner, M., Alfonso, F. and Kastrati, A. (2014) Drug-Coated Balloon Therapy in Coronary and Peripheral Artery Disease. Nature Reviews Cardiology, 11, 13-23. [Google Scholar] [CrossRef] [PubMed]
[47] Qamar, S.U.R., Spahić, L., Benolić, L., Zivanovic, M. and Filipović, N. (2023) Treatment of Peripheral Artery Disease Using Injectable Biomaterials and Drug-Coated Balloons: Safety and Efficacy Perspective. Pharmaceutics, 15, Article No. 1813. [Google Scholar] [CrossRef] [PubMed]
[48] Fanelli, F., Cannavale, A., Gazzetti, M., et al. (2014) Calcium Burden Assessment and Impact on Drug-Eluting Balloons in Peripheral Arterial Disease. CardioVascular and Interven-tional Radiology, 37, 898-907. [Google Scholar] [CrossRef] [PubMed]
[49] Dake, M.D., Ansel, G.M., Jaff, M.R., et al. (2016) Durable Clin-ical Effectiveness with Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Ran-domized Trial. Circulation, 133, 1472-1483. [Google Scholar] [CrossRef] 
[50] Liistro, F., Angioli, P., Porto, I., et al. (2019) Drug-Eluting Balloon versus Drug-Eluting Stent for Complex Femoropopliteal Arterial Lesions: The DRASTICO Study. Journal of the American College of Cardiology, 74, 205-215. [Google Scholar] [CrossRef] [PubMed]
[51] Bausback, Y., Wittig, T., Schmidt, A., et al. (2019) Drug-Eluting Stent versus Drug-Coated Balloon Revascularization in Patients with Femoropopliteal Arterial Disease. Journal of the American College of Cardiology, 73, 667-679. [Google Scholar] [CrossRef] [PubMed]
[52] Tsujimura, T., Takahara, M., Iida, O., et al. (2021) Clinical Out-comes of Polymer-Free, Paclitaxel-Coated Stents vs Stent Grafts in Peripheral Arterial Disease Patients with Femoropop-liteal Artery Lesions. Journal of Vascular Surgery, 73, 1998-2008.e1. [Google Scholar] [CrossRef] [PubMed]
[53] Haine, A., Schmid, M.J., Schindewolf, M., et al. (2019) Comparison between Interwoven Nitinol and Drug Eluting Stents for Endovascular Treatment of Femoropopliteal Artery Disease. European Journal of Vascular and Endovascular Surgery, 58, 865-873. [Google Scholar] [CrossRef] [PubMed]
[54] Müller-Hülsbeck, S. (2016) EluviaTM Peripheral Stent System for the Treatment of Peripheral Lesions above the Knee. Expert Opinion on Drug Delivery, 13, 1639-1644. [Google Scholar] [CrossRef] [PubMed]
[55] Kum, S., Ipema, J., Huizing, E., et al. (2021) Outcomes of the Paclitaxel-Eluting Eluvia Stent for Long Femoropopliteal Lesions in Asian Patients with Predominantly Chronic Limb-Threatening Ischemia. Vascular Medicine, 26, 267-272. [Google Scholar] [CrossRef] 
[56] Stavroulakis, K., Torsello, G., Bosiers, M., Argyriou, A., Tsilimparis, N. and Bisdas, T. (2021) 2-Year Outcomes of the Eluvia Drug-Eluting Stent for the Treatment of Complex Femoropopliteal Lesions. JACC: Cardiovascular Interventions, 14, 692-701. [Google Scholar] [CrossRef] [PubMed]
[57] Ichihashi, S., Takahara, M., Yamaoka, T., et al. (2022) Drug Eluting versus Covered Stent for Femoropopliteal Artery Lesions: Results of the ULTIMATE Study. European Journal of Vas-cular and Endovascular Surgery, 64, 359-366. [Google Scholar] [CrossRef] [PubMed]
[58] Gouëffic, Y., Torsello, G., Zeller, T., et al. (2022) Efficacy of a Drug-Eluting Stent versus Bare Metal Stents for Symptomatic Femoropopliteal Peripheral Artery Disease: Primary Re-sults of the EMINENT Randomized Trial. Circulation, 146, 1564-1576. [Google Scholar] [CrossRef] 
[59] Soga, Y., Fujihara, M., Tomoi, Y., et al. (2020) One-Year Late Lumen Loss between a Polymer-Coated Paclitaxel-Eluting Stent (Eluvia) and a Polymer-Free Paclitax-el-Coated Stent (Zilver PTX) for Femoropopliteal Disease. Journal of Atherosclerosis and Thrombosis, 27, 164-171. [Google Scholar] [CrossRef] [PubMed]
[60] Gray, W.A., Keirse, K., Soga, Y., et al. (2018) A Polymer-Coated, Paclitax-el-Eluting Stent (Eluvia) versus a Polymer-Free, Paclitaxel-Coated Stent (Zilver PTX) for Endovascular Femoropopliteal Intervention (IMPERIAL): A Randomised, Non-Inferiority Trial. The Lancet, 392, 1541-1551. [Google Scholar] [CrossRef] 
[61] Nagatomi, S., Takahara, M., Nakai, T., et al. (2023) Com-paring the Impact of the Loss of Patency between Treatment with Drug-Coated Balloon Angioplasty and Drug-Eluting Stent Placement. Journal of Vascular Surgery, 77, 1751-1759. [Google Scholar] [CrossRef] [PubMed]
[62] Steiner, S., Honton, B., Langhoff, R., et al. (2022) 2-Year Results with a Sirolimus-Eluting Self-Expanding Stent for Femoropopliteal Lesions: The First-in-Human ILLUMINA Study. JACC: Cardiovascular Interventions, 15, 618-626. [Google Scholar] [CrossRef] [PubMed]
[63] Spreen, M.I., Martens, J.M., Knippenberg, B., et al. (2017) Long-Term Follow-Up of the PADI Trial: Percutaneous Transluminal Angioplasty versus Drug-Eluting Stents for In-frapopliteal Lesions in Critical Limb Ischemia. Journal of the American Heart Association, 6, e004877. [Google Scholar] [CrossRef] 
[64] Spreen, M.I., Martens, J.M., Hansen, B.E., et al. (2016) Percuta-neous Transluminal Angioplasty and Drug-Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia (PADI) Trial. Circulation: Cardiovascular Interventions, 9, e002376.
[65] Siablis, D., Kitrou, P.M., Spiliopoulos, S., Katsanos, K. and Karnabatidis, D. (2014) Paclitaxel-Coated Balloon Angioplasty versus Drug-Eluting Stenting for the Treatment of Infrapopliteal Long-Segment Arterial Occlusive Disease: The IDEAS Randomized Controlled Trial. JACC: Cardiovas-cular Interventions, 7, 1048-1056. [Google Scholar] [CrossRef] [PubMed]
[66] Scheinert, D., Katsanos, K., Zeller, T., et al. (2012) A Prospective Randomized Multicenter Comparison of Balloon Angioplasty and Infrapopliteal Stenting with the Sirolimus-Eluting Stent in Patients with Ischemic Peripheral Arterial Disease: 1-Year Results from the ACHILLES Trial. Journal of the American College of Cardiology, 60, 2290-2295. [Google Scholar] [CrossRef] [PubMed]
[67] Rastan, A., Tepe, G., Krankenberg, H., et al. (2011) Siroli-mus-Eluting Stents vs. Bare-Metal Stents for Treatment of Focal Lesions in Infrapopliteal Arteries: A Double-Blind, Multi-Centre, Randomized Clinical Trial. European Heart Journal, 32, 2274-2281. [Google Scholar] [CrossRef] [PubMed]
[68] Bosiers, M., Scheinert, D., Peeters, P., et al. (2012) Randomized Comparison of Everolimus-Eluting versus Bare-Metal Stents in Patients with Critical Limb Ischemia and Infrapopliteal Arterial Occlusive Disease. Journal of Vascular Surgery, 55, 390-398. [Google Scholar] [CrossRef] [PubMed]
[69] Fong, K.Y., Xin, L., Ng, J., Loh, S.E.K., Ng, J.J. and Choong, A.M.T.L. (2023) A Systematic Review and Meta-Analysis of Sirolimus-Eluting Stents for Treatment of Below-the-Knee Arterial Disease. Journal of Vascular Surgery, 77, 1264-1273.e3. [Google Scholar] [CrossRef] [PubMed]
[70] Fusaro, M., Cassese, S., Ndrepepa, G., et al. (2013) Drug-Eluting Stents for Revascularization of Infrapopliteal Arteries: Updated Meta-Analysis of Randomized Trials. JACC: Cardiovas-cular Interventions, 6, 1284-1293. [Google Scholar] [CrossRef] [PubMed]
[71] Katsanos, K., Spiliopoulos, S., Diamantopoulos, A., Karnabatidis, D., Sabharwal, T. and Siablis, D. (2013) Systematic Review of Infrapopliteal Drug-Eluting Stents: A Meta-Analysis of Randomized Controlled Trials. CardioVascular and Interventional Radiology, 36, 645-658. [Google Scholar] [CrossRef] [PubMed]
[72] Liu, X., Zheng, G. and Wen, S. (2017) Drug-Eluting Stents ver-sus Control Therapy in the Infrapopliteal Disease: A Meta-Analysis of Eight Randomized Controlled Trials and Two Cohort Studies. International Journal of Surgery, 44, 166-175. [Google Scholar] [CrossRef] [PubMed]
[73] Nakama, T., Takahara, M., Iwata, Y., et al. (2022) 1-Year Out-comes of Thromboendarterectomy vs Endovascular Therapy for Common Femoral Artery Lesions: CAULIFLOWER Study Results. JACC: Cardiovascular Interventions, 15, 1453-1463. [Google Scholar] [CrossRef] [PubMed]
[74] Kuo, T.T., Chen, P.L., Huang, C.Y., Lee, C.Y., Shih, C.C. and Chen, I.M. (2019) Outcome of Drug-Eluting Balloon Angioplasty versus Endarterectomy in Common Femoral Artery Occlusive Disease. Journal of Vascular Surgery, 69, 141-147. [Google Scholar] [CrossRef] [PubMed]
[75] Saucy, F., Probst, H. and Trunfio, R. (2020) Vessel Preparation Is Essential to Optimize Endovascular Therapy of Infrainguinal Lesions. Frontiers in Cardiovascular Medicine, 7, Article ID: 558129. [Google Scholar] [CrossRef] [PubMed]
[76] Mustapha, J.A., Lansky, A., Shishehbor, M., et al. (2018) A Pro-spective, Multi-Center Study of the Chocolate Balloon in Femoropopliteal Peripheral Artery Disease: The Chocolate BAR Registry. Catheterization and Cardiovascular Interventions, 91, 1144-1148. [Google Scholar] [CrossRef] [PubMed]
[77] Shimada, Y., Kino, N., Tonomura, D., et al. (2019) Efficacy of Cutting Balloon Angioplasty for Chronic Total Occlusion of Femoropopliteal Arteries. Annals of Vascular Surgery, 58, 91-100. [Google Scholar] [CrossRef] [PubMed]
[78] Kronlage, M., Werner, C., Dufner, M., et al. (2020) Long-Term Outcome upon Treatment of Calcified Lesions of the Lower Limb Using Scoring Angioplasty Balloon (AngioSculptTM). Clinical Research in Cardiology, 109, 1177-1185. [Google Scholar] [CrossRef] [PubMed]
[79] Böhme, T., Zeller, T., Shishehbor, M.H., et al. (2023) Chocolate Touch versus Lutonix Drug-Coated Balloon for Femoropopliteal Lesions in Diabetes: The Chocolate Touch Study. Journal of Endovascular Therapy. [Google Scholar] [CrossRef] [PubMed]
[80] Scalamogna, M., Kuna, C., Voll, F., et al. (2023) Modified Bal-loons to Prepare Severely Calcified Coronary Lesions before Stent Implantation: A Systematic Review and Me-ta-Analysis of Randomized Trials. Clinical Research in Cardiology. [Google Scholar] [CrossRef] [PubMed]
[81] Giusca, S., Hagstotz, S., Lichtenberg, M., et al. (2022) Phoenix Atherectomy for Patients with Peripheral Artery Disease. EuroIntervention, 18, e432-e442. [Google Scholar] [CrossRef] 
[82] McKinsey, J.F., Zeller, T., Rocha-Singh, K.J., Jaff, M.R., Garcia, L.A. and Definitive Le Investigators (2014) Lower Extremity Revascularization Using Directional Atherectomy: 12-Month Prospective Results of the DEFINITIVE LE Study. JACC: Cardiovascular Interventions, 7, 923-933. [Google Scholar] [CrossRef] [PubMed]
[83] Maehara, A., Mintz, G.S., Shimshak, T.M., et al. (2015) Intravas-cular Ultrasound Evaluation of JETSTREAM Atherectomy Removal of Superficial Calcium in Peripheral Arteries. Eu-roIntervention, 11, 96-103. [Google Scholar] [CrossRef] 
[84] Rastan, A., Brodmann, M., Böhme, T., et al. (2021) Atherectomy and Drug-Coated Balloon Angioplasty for the Treatment of Long Infrapopliteal Lesions: A Randomized Controlled Trial. Circulation: Cardiovascular Interventions, 14, e010280. [Google Scholar] [CrossRef] 
[85] Wong, C.P., Chan, L.P., Au, D.M., Chan, H.W.C. and Chan, Y.C. (2022) Efficacy and Safety of Intravascular Lithotripsy in Lower Extremity Peripheral Artery Disease: A Systematic Review and Meta-Analysis. European Journal of Vascular and Endovascular Surgery, 63, 446-456. [Google Scholar] [CrossRef] [PubMed]
[86] Tepe, G., Brodmann, M., Werner, M., et al. (2021) Intra-vascular Lithotripsy for Peripheral Artery Calcification: 30-Day Outcomes from the Randomized Disrupt PAD III Trial. JACC: Cardiovascular Interventions, 14, 1352-1361. [Google Scholar] [CrossRef] [PubMed]
[87] Clair, D.G., Mustapha, J.A., Shishehbor, M.H., et al. (2021) PROMISE I: Early Feasibility Study of the LimFlow System for Percutaneous Deep Vein Arterialization in No-Option Chronic Limb-Threatening Ischemia: 12-Month Results. Journal of Vascular Surgery, 74, 1626-1635. [Google Scholar] [CrossRef] [PubMed]
[88] Schmidt, A., Schreve, M.A., Huizing, E., et al. (2020) Midterm Outcomes of Percutaneous Deep Venous Arterialization with a Dedicated System for Patients with No-Option Chronic Limb-Threatening Ischemia: The ALPS Multicenter Study. Journal of Endovascular Therapy, 27, 658-665. [Google Scholar] [CrossRef] [PubMed]
[89] Shishehbor, M.H., Powell, R.J., Montero-Baker, M.F., et al. (2023) Transcatheter Arterialization of Deep Veins in Chronic Limb-Threatening Ischemia. The New England Journal of Medicine, 388, 1171-1180. [Google Scholar] [CrossRef] 
[90] Beshchasna, N., Saqib, M., Kraskiewicz, H., et al. (2020) Recent Advances in Manufacturing Innovative Stents. Pharmaceutics, 12, Article No. 349. [Google Scholar] [CrossRef] [PubMed]
[91] Varcoe, R.L., Schouten, O., Thomas, S.D. and Lennox, A.F. (2016) Experience with the Absorb Everolimus-Eluting Bioresorbable Vascular Scaffold in Arteries below the Knee: 12-Month Clinical and Imaging Outcomes. JACC: Cardiovascular Interventions, 9, 1721-1728. [Google Scholar] [CrossRef] [PubMed]

为你推荐